Health Care/Hospital
LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study
SAN DANIELE DEL FRIULI, Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study. This randomized, multi-center comparative clinical trial is currently evaluating t...
2021-04-20 20:00
2288
Mindray Unlocks Vast Patient Monitoring Potential with M-Connect Universally Connected Platform
SHENZHEN, China, April 20, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a leading global developer and provider of medical devices and integrated solutions, has launched its universally connected platform, M-Connect, which unlocks the potential of individual patient monitoring with an integrated ...
2021-04-20 15:00
5244
Holmusk continues ambitious US growth with NYC headquarters and expanded management team
NEW YORK, April 20, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters inNew York City and addition of three new members to its manage...
2021-04-20 14:00
2110
One Year After COVID-19 Global Lockdown, Medical Panel Discusses Pandemic Impact on Patients with Underlying Conditions and the Need to Prioritize Chronic Diseases in the Future
WASHINGTON, April 20, 2021 /PRNewswire/ -- On Wednesday, April 21st, 2021, from 8:00AM - 9:30AM EDT, the Business Council for International Understanding (BCIU) and Viatris (NASDAQ: VTRS) will co-host a virtual dialogue following the 2021 Spring Meetings of the World Bank Group and the Internatio...
2021-04-20 11:53
3254
Prenetics Signs Multi-million Dollar Collaboration with Oxford University for Advanced Molecular Diagnostics
* The collaboration is a 3-year joint effort by Prenetics R&D Team, Oxford University and Oxford Suzhou for Advanced Research (OSCAR) for Molecular Diagnostics * A new Prenetics Innovation Technology Centre is established for advanced molecular diagnostics * Collaboration follows successful...
2021-04-20 09:00
2132
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration
SHENZHEN, China, April 19, 2021 /PRNewswire/ -- On April 15, 2021, ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration through publication in a virtual poster at the AACR annual meeting. MVR-T3011 is a replication competent and genetically modified oncolyti...
2021-04-20 08:30
2033
3 International Cancer Researchers to Receive the 2021 Fondation ARC Léopold Griffuel Prize
PARIS, April 20, 2021 /PRNewswire/ -- Whilst the Fondation ARC Léopold Griffuel Prize is widely recognised today as one of the most prestigious European awards in the field of cancer research, many people are unaware of the story behind it. It is the story of Léopold and Alice Griffuel, a couple ...
2021-04-20 08:30
822
iMDsoft announces Dedalus as their Channel Partner in Australia and New Zealand for MetaVision Clinical Information System, iMDsoft's best of class product suite
BRISBANE, Australia, April 20, 2021 /PRNewswire/ -- iMDsoft Ltd. and Dedalus are pleased to announce their Channel Partner Agreement, authorizing Dedalus to distribute MetaVision licenses and services, and support customers inAustralia andNew Zealand (ANZ). Through its Channel Partner program, i...
2021-04-20 07:01
2179
Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge
- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid Test Device comes with an easy-to-use nasal swab to detect active coronavirus infections in as earl...
2021-04-20 06:00
5294
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform
LAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Technologies and CSL Plasma today announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial of the investigational plasmapheresis device ...
2021-04-20 05:00
2617
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer
SAN DIEGO, April 20, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based ...
2021-04-20 01:42
2699
Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study
LAVA clinical trial underway for potential first FDA-approved liquid embolic system for a peripheral vascular indication WOBURN, Mass., April 20, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a B...
2021-04-20 00:57
1656
ASG Superconductors with HZDR combine magnetic resonance imaging with proton therapy
Towards live imaging in cancer therapy GENOA, Italy, April 19, 2021 /PRNewswire/ -- ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world's first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, comb...
2021-04-19 22:56
2843
AACR Annual Meeting 2021: AnchorDx Unveils High-Performance Blood Test for Gastric Cancer Screening
GUANGZHOU, China, April 19, 2021 /PRNewswire/ -- At this year's American Association for Cancer Research (AACR) Annual Meeting 2021 (April 10-15), molecular diagnostic company AnchorDx presented a poster (Poster 2610) unveiling its Aurora 2.0 study results. The poster introduced the company's up...
2021-04-19 21:00
2504
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port
HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy statements in "Several Special Measures to Support the Construction of Hainan Free Trade Port to Rel...
2021-04-19 20:30
3690
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection
- Trail-blazing diversification of the repurposing of Niclosamide - Full-scale clinical preparation of injections for severely ill patients SEOUL, South Korea, April 19, 2021 /PRNewswire/ -- Hyundai Bioscience (Symbol 048410), a KOSDAQ listed company, announced on the 19th that its major sharehol...
2021-04-19 20:15
2070
Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy
SUZHOU, China, April 19, 2021 /PRNewswire/ -- On April 16, 2021, Suzhou Porton BiologicsLtd. (hereinafter referred to as Porton Biologics), a subsidiary of Porton Pharma Solutions Ltd. (hereinafter referred to as Porton Pharma Solutions) (300363.SZ), which focuses on gene and cell therapy CDMO se...
2021-04-19 20:00
4919
Happiness Biotech Officially Launched Cross-Border E-commerce Platform- Happy Buy International
NANPING, China, April 19, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer and e-commerce services provider, announced today that the Company has officially launched cross-border e-commerc...
2021-04-19 20:00
5321
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC
DAEJEON, South Korea, April 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company has entered into an agreement with MSD to initiate a Phase II combination trial of olin...
2021-04-19 20:00
1857
Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, from Evotec SE
SYDNEY, April 19, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce that it has entered into a worldwide exclusive licensing agreement and a master services agreement with Evotec SE (FRA: EVT), a leading ...
2021-04-19 17:54
4024
Week's Top Stories
Most Reposted
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
[Picked up by 311 media titles]
2026-01-15 13:00Colebrook Bosson Saunders Launches Lana: An Adaptable Laptop Stand Engineered for Hybrid Work
[Picked up by 305 media titles]
2026-01-12 16:16
Ready Server Announces Strategic Expansion into Japan with AT TOKYO Data Centre
[Picked up by 301 media titles]
2026-01-13 13:16
CAYIN AI: Revolutionizing Creativity and Global Communication
[Picked up by 300 media titles]
2026-01-12 16:34
JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
[Picked up by 299 media titles]
2026-01-15 10:00Most Read
CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
2026-01-11 04:10
4644
Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame's Core Company
2026-01-12 04:50
3749
